Pfizer has entered a $43 billion merger agreement with biotechnology firm Seagen. The deal is designed to bolster the pharmaceutical giant's efforts to fight cancer by scaling up the production of a promising antibody drug. 

“Pfizer is deploying its financial resources to advance the battle against cancer, a leading cause of death worldwide with a significant impact on public health,” said CEO Dr. Albert Bourla. 

“Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen’s antibody-drug conjugate (ADC) technology with the scale and strength of Pfizer’s capabilities and expertise." 

ADCs are designed to kill cancer cells and limit off-target toxicities. Bourla noted that oncology is the "largest growth driver in global medicine," and that the deal would improve Pfzier's position in the space. 

Seagen forecast $2.2 billion in revenue in 2023, up 12 percent from last year. Pfizer said the company could contribute $10 billion in risk-adjusted revenues by 2030. This would supplement the company's existing oncology division, which brought in  $12 billion in revenue in 2022 with a combination of prostate cancer and the breast cancer treatments. 

“Pfizer shares our steadfast commitment to patients, and this combination is a testament to the passion, dedication and talent of the Seagen team to achieve our mission to discover, develop, and commercialize transformative cancer medicines that make a meaningful difference in people’s lives,” said Seagan CEO David Epstein. 

Share:
More In Business
The Day Ahead: Debt Ceiling Talks, Corporate Earnings
Cheddar News checks in on what to look for on The Day Ahead as President Joe Biden meets with House Speaker Kevin McCarthy to look to resolve the debt ceiling debate. Earnings are also slated to be reported from companies including Airbnb, AMC Networks, Electronic Arts and Nintendo.
Stretching Your Dollar: What Bank Failures Mean for Mortgage
A study on the U.S. banking system found nearly 190 banks are at risk of failure. Preston D. Cherry, founder and president of Concurrent Financial Planning, joined Cheddar News to explain the process if you have a mortgage with a bank that collapses.
Analyst Discusses Monday's Mixed Market Performance Ahead of Key Inflation Data
Melissa Brown, managing director of applied research with Qontigo, joined Cheddar News to discuss a new start to the trading week as the market edged lower in a mixed-performance day. Investors also await the meeting between President Joe Biden and House Speaker Kevin McCarthy to look to resolve its debt ceiling debate.
Load More